Dose Escalation of SNK-396 in Participants With Elevated Low-Density Lipoprotein Cholesterol
Clinical trial NCT05896969 · COMPLETED
Trial details
- NCT number
- NCT05896969
- Sponsor
- Syneos Health
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-27
- Primary completion
- 2024-02-23
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.